{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T23:37:17Z","timestamp":1786405037384,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1K23EY019511"],"award-info":[{"award-number":["1K23EY019511"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.ophtha.2014.11.022","type":"journal-article","created":{"date-parts":[[2015,2,9]],"date-time":"2015-02-09T16:35:41Z","timestamp":1423499741000},"page":"738-747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Impact of the Introduction of Generic Latanoprost on Glaucoma Medication Adherence"],"prefix":"10.1016","volume":"122","author":[{"given":"Joshua D.","family":"Stein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4472-3852","authenticated-orcid":false,"given":"Nakul","family":"Shekhawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Talwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Balkrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2014.11.022_bib1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9394(14)74225-4","article-title":"Compliance with topical timolol treatment","volume":"103","author":"Kass","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.11.022_bib2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2105\/AJPH.83.5.711","article-title":"Treatment for glaucoma: adherence by the elderly","volume":"83","author":"Gurwitz","year":"1993","journal-title":"Am J Public Health"},{"key":"10.1016\/j.ophtha.2014.11.022_bib3","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ophtha.2004.12.035","article-title":"Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review","volume":"112","author":"Olthoff","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.11.022_bib4","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ajo.2005.04.051","article-title":"Persistence and adherence with topical glaucoma therapy","volume":"140","author":"Nordstrom","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.11.022_bib5","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1167\/iovs.07-0290","article-title":"Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS)","volume":"48","author":"Friedman","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2014.11.022_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ophtha.2008.09.004","article-title":"Adherence with topical glaucoma medication monitored electronically: the Travatan Dosing Aid study","volume":"116","author":"Okeke","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.11.022_bib7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/IJG.0b013e31821dac86","article-title":"Determinants of medication adherence to topical glaucoma therapy","volume":"21","author":"Dreer","year":"2012","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.ophtha.2014.11.022_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/IJG.0b013e31819c4679","article-title":"An exploratory study of factors influencing glaucoma treatment adherence","volume":"19","author":"Stryker","year":"2010","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.ophtha.2014.11.022_bib9","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/eye.2008.103","article-title":"Barriers to adherence with glaucoma medications: a qualitative research study","volume":"23","author":"Lacey","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2014.11.022_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00061198-200310000-00001","article-title":"Compliance barriers in glaucoma: a systematic classification","volume":"12","author":"Tsai","year":"2003","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.ophtha.2014.11.022_bib11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/10807680260362687","article-title":"Causes of non-compliance with drug regimens in glaucoma patients: a qualitative study","volume":"18","author":"Taylor","year":"2002","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2014.11.022_bib12","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ajo.2006.12.025","article-title":"Rates of glaucoma medication utilization among older adults with suspected glaucoma","volume":"143","author":"Stein","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.11.022_bib13","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.ophtha.2007.12.017","article-title":"Rates of glaucoma medication utilization among persons with primary open-angle glaucoma, 1992 to 2002","volume":"115","author":"Stein","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.11.022_bib14","unstructured":"Engel K, ed. Red Book. Truven Health Analytics. Available at: http:\/\/sites.truvenhealth.com\/redbook\/. Accessed July 2,\u00a02014."},{"key":"10.1016\/j.ophtha.2014.11.022_bib15","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.ajo.2013.06.035","article-title":"Identification of persons with incident ocular diseases using health care claims databases","volume":"156","author":"Stein","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.11.022_bib16","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archophthalmol.2011.191","article-title":"Geographic and climatic factors associated with exfoliation syndrome","volume":"129","author":"Stein","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.11.022_bib17","doi-asserted-by":"crossref","first-page":"6842","DOI":"10.1167\/iovs.11-7179","article-title":"Rates of nonexudative and exudative age-related macular degeneration among Asian American ethnic groups","volume":"52","author":"Stein","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2014.11.022_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/jamaophthalmol.2013.577","article-title":"Accuracy of international classification of diseases, ninth revision, clinical modification billing codes for common ophthalmic conditions","volume":"131","author":"Muir","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.11.022_bib19","first-page":"1280","article-title":"Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures","volume":"40","author":"Hess","year":"2006","journal-title":"Ann Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2014.11.022_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/02713683.2011.631722","article-title":"A\u00a0comparison of active ingredients and preservatives between brand name and generic topical glaucoma medications using liquid chromatography-tandem mass spectrometry","volume":"37","author":"Kahook","year":"2012","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ophtha.2014.11.022_bib21","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/IJG.0b013e318259b47c","article-title":"An evaluation of therapeutic noninferiority of 0.005% latanoprost ophthalmic solution and Xalatan in patients with glaucoma or ocular hypertension","volume":"22","author":"Digiuni","year":"2013","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.ophtha.2014.11.022_bib22","first-page":"233","article-title":"Compliance in patients prescribed eyedrops for glaucoma","volume":"26","author":"Patel","year":"1995","journal-title":"Ophthalmic Surg"},{"key":"10.1016\/j.ophtha.2014.11.022_bib23","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.ophtha.2007.11.023","article-title":"Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study","volume":"115","author":"Friedman","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.11.022_bib24","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.ophtha.2009.01.021","article-title":"Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma","volume":"116","author":"Friedman","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.11.022_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.amjopharm.2009.04.001","article-title":"Self-reported prevalence and factors associated with nonadherence with glaucoma medications in veteran outpatients","volume":"7","author":"Sleath","year":"2009","journal-title":"Am J Geriatric Pharmacother"},{"key":"10.1016\/j.ophtha.2014.11.022_bib26","doi-asserted-by":"crossref","first-page":"902819","DOI":"10.5402\/2012\/902819","article-title":"Patient race, reported problems in using glaucoma medications, and adherence","volume":"2012","author":"Sleath","year":"2012","journal-title":"ISRN Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.11.022_bib27","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0149-2918(04)90063-X","article-title":"Drug affordability and prescription noncompliance in the United States: 1997\u20132002","volume":"26","author":"Kennedy","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.ophtha.2014.11.022_bib28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2014.11.022_bib29","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.ophtha.2009.06.024","article-title":"A\u00a0comprehensive perspective on patient adherence to topical glaucoma therapy","volume":"116","author":"Tsai","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.11.022_bib30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ophtha.2005.10.034","article-title":"Patient-reported behavior and problems in using glaucoma medications","volume":"113","author":"Sleath","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.11.022_bib31","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/OPX.0000000000000009","article-title":"Glaucoma medication adherence among African Americans: program development","volume":"90","author":"Dreer","year":"2013","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.ophtha.2014.11.022_bib32","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1161\/CIRCULATIONAHA.108.783944","article-title":"Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans","volume":"119","author":"Doshi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ophtha.2014.11.022_bib33","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0149-2918(98)80139-2","article-title":"Predictors of medication adherence in the elderly","volume":"20","author":"Balkrishnan","year":"1998","journal-title":"Clin Ther"},{"key":"10.1016\/j.ophtha.2014.11.022_bib34","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.ophtha.2012.02.029","article-title":"Validity of self-reported eye disease and treatment in a population-based study: the Los Angeles Latino Eye Study","volume":"119","author":"Patty","year":"2012","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642014011166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642014011166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:05:40Z","timestamp":1758981940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642014011166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0161642014011166"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2014.11.022","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of the Introduction of Generic Latanoprost on Glaucoma Medication Adherence","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2014.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}